Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00702000
Other study ID # 2008H0081
Secondary ID
Status Completed
Phase N/A
First received June 17, 2008
Last updated January 15, 2016
Start date May 2008
Est. completion date May 2010

Study information

Verified date January 2016
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

To better understand ICU-acquired weakness in patients requiring mechanical ventilation in the Intensive Care Unit.


Description:

We have generated the hypothesis that handgrip strength can be used to develop our understanding of the effects of critical illness on peripheral muscle strength.

To begin to develop this hypothesis, a better understanding of the determinants of handgrip strength needs to be developed. As a result we propose to perform a prospective observational study examining the clinical factors that are associated with handgrip strength. Several clinical factors are known to be associated with increased risk of developing ICUAP while hospitalized: multiple organ failure, severe sepsis, female gender and treatments like steroids. As many of these risk factors are not modifiable, the opportunity to intervene is unclear. However, by attempting to better describe the spectrum of strength deficits experienced by critically ill patients we may better be able to dissect and prevent ICUAP.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date May 2010
Est. primary completion date May 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- • Adult patients admitted to the Medical ICU

- Age = 18 years of age at ICU admit.

- Requiring mechanical ventilation for at least 24 hours

Exclusion Criteria:

- • Moribund or in the process of withdrawal of life support

- Patient, family or physicians not in favor of continued support until awakening.

- Profound neurologic injury associated with little or no chance of awakening.

- Active consideration of a diagnosis of brain death by treating physicians.

- Known history of chronic neurological disease resulting in muscle weakness in more than two limbs.

- Inability to perform handgrip dynamometry prior to acute illness.

- Subject is a Non-english speaker

- Subject or surrogate unable to provide informed consent.

- ICU stay of greater than 24 hours within the last thirty days or at any point during the current hospitalization

- Greater than seven days of hospital care prior to hospital admission.

- Greater than five days since inclusion criteria met.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States The Ohio State University Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Naeem Ali, MD

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the feasibility of performing serial assessments of strength (handgrip and limb muscle strength) in a broad population of critically ill patients. duration of ICU stay-up to 10 days No
Secondary To determine the acute medical illnesses associated with weakness duration of ICU stay-up to 10 days No
Secondary To determine the modifiable risk factors associated with weakness duration of ICU stay-up to 10 days No
Secondary To determine if there is an association between handgrip strength and ICUAP risk duration of ICU stay-up to 10 days No
Secondary To generate a set of normative data for handgrip strength in critically ill patients adjusting for important non-modifiable risk factors duration of ICU stay-up to 10 days No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05665673 - Relation of Functional ındependence to Balance, Exercise Capacity, and Peripheral Muscle Strength